Navigation Links
Simcere Announces Recent Progress of Qiangke's Registration
Date:5/9/2011

NANJING, China, May 9, 2011 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that Shanghai Celgen Bio-Pharmaceutical Co., Ltd. ("Shanghai Celgen") , in which it holds a 35% equity interest, has received new drug registration approval for Qiangke, its Recombinant Human TNF Receptor-IgG Fusion Protein for Injection. Qiangke is primarily used for in-patient treatment of ankylosing spondylitis and holds strong market potential. Shanghai Celgen is currently preparing for the upcoming GMP inspection by the SFDA.

In addition, Simcere plans to purchase the land use rights to 65,300 square meters in Beijing's Zhongguancun Innovation Park to establish a regional R&D center and offices. The purchase will allow Simcere to take advantage of the talent, technology, and resources available in Beijing.  Simcere has signed a framework agreement with Beijing Strong Science Park Development Co., Ltd. for this project.

About Simcere Pharmaceutical GroupSimcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China. In recent years, Simcere has been focusing its strategy on the development of innovative pharmaceuticals and first-to-market generics. The Company has introduced an innovative anti-cancer medication Endu, first-to-market generics such as Bicun and Anxin, and a first-to-market medication Sinofuan. Simcere manufactures and sells drugs in the oncological, cardiovascular, anti-inflammatory and anti-infection therapeutical areas. Simcere concentrates its research and development efforts on the treatment of diseases with high i
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
2. Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
3. Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
4. Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production
5. Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
6. Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China
7. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Tuesday, March 16, 2010
8. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
9. Simceres Diosmectite API Passes EU-GMP Inspection
10. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
11. Simcere Pharmaceutical Group Files Annual Report on Form 20-F
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015  Boston Scientific Corporation (NYSE: ... continued business momentum and long-term growth strategies at a ... New York City . President and Chief Executive ... opportunities the company has to bring forward meaningful innovation ... markets and deliver shareholder value. "We ...
(Date:5/1/2015)... 1, 2015  Shares of Aerie Pharmaceuticals, Inc. (NASDAQ: ... yesterday following the results of the Phase 3 Rocket ... the trial failing to meet its end points, compelling ... come from future studies. An analyst report ... pipeline, financial review, analyst summary, valuation, and recommendation can ...
(Date:4/30/2015)... 30, 2015  IRIDEX Corporation (NASDAQ: IRIX ) ... 2015 financial results after the market closes on ... release, the Company will host a conference call with ... on Thursday, May 7, 2015 to ... developments. Interested parties may access the live ...
Breaking Medicine Technology:Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 2Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 3Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 5Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 6Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 7All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2IRIDEX Announces First Quarter 2015 Conference Call and Release Date 2
... certain mutations enable specific cells in the,retina to ... suggests deliberate,genetic manipulations might coax an injured brain ... Investigators at St.,Jude Children,s Research Hospital have ... cancer retinoblastoma, disproving a long-standing principle of,nerve growth ...
... Oct. 18 CEL-SCI CORPORATION,(Amex: CVM ) ... is a featured presenter at the International Society ... Mr. Kersten will present on the "New Realities ... p.m. (Eastern Daylight,Time). In April 2007, CEL-SCI ...
Cached Medicine Technology:St. Jude Identifies the Specific Cell That Causes Eye Cancer, Disproving Long-Held Theory 2St. Jude Identifies the Specific Cell That Causes Eye Cancer, Disproving Long-Held Theory 3CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase 2
(Date:5/3/2015)... 03, 2015 AvePoint, ... platforms and devices, today announced it is a ... Professionals (IAPP) Asia Privacy Forum, taking place May ... the event, AvePoint will showcase its compliance, risk, ... platforms. , Visit AvePoint for New Solutions ...
(Date:5/3/2015)... " Bubbly Walrus ” was featured on NewsWatch ... at the latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... The best games to play on smartphones are the ones ... brain cells with a video game that just absorbs attention, ...
(Date:5/3/2015)... 03, 2015 SpineFrontier, a Less Exposure ... FDA to produce and market their new sacroiliac joint ... used in outpatient settings and is compatible with both ... approach has been extensively researched and refined by SpineFrontier, ... use this approach in conjunction with a sacroiliac joint ...
(Date:5/2/2015)... Vancouver fencing company, QS Fencing, has recently announced ... prospective clients related to their questions on railings and gates. ... their decks and patios. While that seems like an easy ... the person rolls up their sleeve to start working. One ... finding a gate that matches it. , Instead of spending ...
(Date:5/2/2015)... Peachtree Audio ” was featured on NewsWatch as part ... and coolest technology products available to consumers. Scott Steinberg, ... the review and shared with viewers how this is ... important part of people’s lives – and as such, ... Peachtree Audio does just that with high-end audio equipment ...
Breaking Medicine News(10 mins):Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 2Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 3Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 4Health News:An Application to Have Fun with Mathematics Was Featured on NewsWatch Television 2Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2
... , WASHINGTON, July 24 Today the ... Mike Pence (R-Ind.) that would have prevented family planning funds ... to Planned Parenthood. The amendment was to be attached ... Planned Parenthood is the nation,s largest abortion organization, and ...
... , , , SANTA MONICA, Calif., July 24 The ... , Wendell Potter, former head of corporate communications for CIGNA health insurance , ... , , Where : , Hilton ... Level , 333 O,Farrell Street , San Francisco, CA 94102 , ...
... stigma barriers to prevention and treatment for this hard-hit group, ... new study finds that the high death rates from breast ... to cultural beliefs, not barriers such as poor access to ... ranks second on the list of cancer-related deaths in American ...
... central nervous system has long been considered impossible, French ... just developed a strategy that could promote neuronal regeneration ... published in the journal PLoS ONE . , ... voluntary motor activity through axonal re-growth has long been ...
... , Despite Rising Unemployment, the ... , , COSTA MESA, Calif., July ... USA continues to see job opportunities for qualified professionals in the ... rate is over 11%, Adecco USA currently has demand for 300 ...
... WASHINGTON, July 24 After reviewing scientific studies of the ... of Sciences has determined there is "limited or suggestive evidence" of ... to Agent Orange. , , "We ... conclusions," said John Rowan, National President of Vietnam Veterans of America ...
Cached Medicine News:Health News:CIGNA Whistleblower Calls for More Heath Insurance Accountability in Heath Care Reform 2Health News:Culture May Help Raise Breast Cancer Death Rate for American Indians 2Health News:Neuronal survival and axonal regrowth obtained in vitro 2Health News:Wanted: Orange County, California Licensed Pharmacy Technicians 2Health News:Wanted: Orange County, California Licensed Pharmacy Technicians 3
... Clamps have a slender design contributes to ... of Kirschner wires. The Connecting Clamp allows ... and/or Connecting Bar. Uses 3.0 mm Carbon ... wires eliminate need to predrill and provide ...
The Medium External Fixator has a double-rod frame, medium Combination Clamp medium Multi-Pin Clamp, and Carbon Fiber Rods. Rod Attachment for Medium Multi-Pin Clamp allows second rod to be added....
... long-standing tradition of the original Hoffmann® ... today's surgeon with advanced technology and ... loaded snap fit mechanism allows the ... rods or pins providing versatile intraoperative ...
... X-ray contrast medium for use ... angiography, urography, phlebography and CT-enhancement. ... the basal cisterns, following subarachnoid ... (pancreato) graphy (ERC(P)), herniography, hysterosalpingography, ...
Medicine Products: